WP-1034 是一种 JAK-STAT 抑制剂,可阻断 Stat 3 和 Stat 5 的激活,在急性髓系白血病 (AML) 中具有促凋亡和抗白血病活性,能诱导细胞周期阻滞并触发细胞凋亡 (apoptosis),可用于 AML 研究。
产品编号: MS-P15873 CAS No.: 857064-42-7 分子式: C18H15N3O3 分子量: 321.33
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

WP-1034 是一种 JAK-STAT 抑制剂,可阻断 Stat 3 和 Stat 5 的激活,在急性髓系白血病 (AML) 中具有促凋亡和抗白血病活性,能诱导细胞周期阻滞并触发细胞凋亡 (apoptosis),可用于 AML 研究。

生物实验数据

生物活性 WP-1034 is a JAK-STAT inhibitor that blocks the activation of Stat 3 and Stat 5, exhibits pro-apoptotic and anti-leukemic activity in acute myeloid leukemia (AML), induces cell cycle arrest and triggers apoptosis, and can be used for AML research.
体外研究
(In Vitro)

WP-1034 (1-6 μM,7 天) 以剂量依赖的方式抑制 OCIM2 和 K562 细胞的集落形成生长,并抑制新鲜 AML 细胞的白血病集落形成与细胞增殖。
WP-1034 (1-10 μM,0-4 小时) 以时间和剂量依赖的方式抑制 OCIM2 细胞中 Stat3 和 Stat5 的磷酸化,表明其能有效抑制 AML 细胞中的 Jak-Stat 信号通路。
WP-1034 (5 μM,0-16 小时) 诱导 OCIM2 细胞发生亚 G0 期细胞周期阻滞。
WP-1034 (3-6 μM) 以剂量依赖的方式诱导 OCIM2 细胞凋亡,并伴有 caspase 3 和 PARP 裂解,而这种作用可被 caspase 抑制剂 Ac-DEVD-CHO (MS-C24356) 阻断。

Cell Proliferation Assay

Cell Line: OCIM2, K562, AML and marrow cells
Concentration: 1, 2, 2.5, 3, 4, 5, 6, 7.5 and 10 μM
Incubation Time: 7 days
Result: Suppressed the colony-forming growth of OCIM2 cells in a dose-dependent manner at concentrations ranging from 1 to 5 μM.
Almost completely abolished cell proliferation at concentrations of ≥4 μM.
Inhibited the proliferation of K562 cells by >80% at concentrations of ≥5 μM.
A concentration of at least 10 μM was necessary to inhibit OCIM2 cell proliferation by >80%.
Inhibited the proliferation of AML colony-forming blasts in a dose-dependent manner at concentrations ranging from 1 to 6 μM.
Suppressed AML colony-forming blast proliferation at more than 50% at 5 μM.
Almost completely inhibited AML proliferation at 6 μM.
Showed a dose-dependent inhibition of the growth of healthy marrow between 4 to 6 μM.
The inhibition of normal marrow cells was less than the inhibition of AML blast cells at the same concentrations.

Western Blot Analysis

Cell Line: OCIM2 cells
Concentration: 1, 2.5, 5, 7.5 and 10 μM
Incubation Time: 20 and 40 min, 1, 2, 3, and 4 h
Result: Reduced phospho-Stat 3 and phospho-Stat 5 levels to undetectable levels after incubation times of ≥1 hour.
Significantly down-regulated Stat 3 and Stat 5 phosphorylation at concentrations of 1, 2.5, 5, 7.5 and 10 μM for 2 hours.
Showed no effect on levels of phospho-Stat 1.
Induced dose-dependent caspase 3 cleavage.
Resulted in a dose-dependent increase in cleaved PARP protein levels.

Cell Cycle Analysis

Cell Line: OCIM2 cells
Concentration: 5 μM
Incubation Time: 0, 2, 4, 6, and 16 h
Result: Induced cell cycle arrest at Sub-G0 phase at 6 hours of incubation, with around 23% of the cells accumulating at sub-G0 phase at 16 hours of incubation.

Apoptosis Analysis

Cell Line: OCIM2 cells
Concentration: 4 μM
Incubation Time: 2 h
Result: Induced apoptotic cell death in OCIM2 cells, and this effect was blocked by the caspase inhibitor Ac-DEVD-CHO.

化学信息

分子量 321.33
分子式 C18H15N3O3
CAS No. 857064-42-7

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础